Biogen Pharmachem Industries (BOM:531752) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531752 Biogen Pharmachem Industries Ltd BOM:531752
30 GF Score
Price ₹0.31
! 1 Warning Sign
View Full Analysis

What is Biogen Pharmachem Industries FCF Margin %?

Biogen Pharmachem Industries BOM:531752 -3.13% 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:531752 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 773 Capital Markets companies, Biogen Pharmachem Industries ranks worse than 129365.98% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biogen Pharmachem Industries's Free Cash Flow for the three months ended in Mar. 2026 was ₹0.00 Mil. Biogen Pharmachem Industries's Revenue for the three months ended in Mar. 2026 was ₹0.00 Mil. Therefore, Biogen Pharmachem Industries's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Biogen Pharmachem Industries's current FCF Yield % is 4.80%.

The historical rank and industry rank for Biogen Pharmachem Industries's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Biogen Pharmachem Industries was 404066.67%. The lowest was 9.21%. And the median was 227.92%.

BOM:531752's FCF Margin % is not ranked *
in the Capital Markets industry.
Industry Median: 1.02
* Ranked among companies with meaningful FCF Margin % only.


Biogen Pharmachem Industries FCF Margin % Related Terms


Biogen Pharmachem Industries FCF Margin % Historical Data

* Premium members only.

The historical data trend for Biogen Pharmachem Industries's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogen Pharmachem Industries FCF Margin % Chart

Biogen Pharmachem Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.68 256.01 121.07 0.00 0.00

Biogen Pharmachem Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:531752 vs MS, GS, SCHW: FCF Margin % Comparison

For the Capital Markets subindustry, Biogen Pharmachem Industries's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogen Pharmachem Industries FCF Margin % vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Biogen Pharmachem Industries's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biogen Pharmachem Industries's FCF Margin % falls into.


BOM:531752
30GF Score
Biogen Pharmachem Industries Ltd BOM:531752
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogen Pharmachem Industries FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biogen Pharmachem Industries's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=15.683/0
= %

Biogen Pharmachem Industries's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Biogen Pharmachem Industries (BOM:531752) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biogen Pharmachem Industries and its competitors. Over the past decade, Biogen Pharmachem Industries' FCF Margin % has ranged from 9.21 to 404,066.67. According to the industry distribution chart, Biogen Pharmachem Industries ranks #999999 out of 773 companies in the Capital Markets industry.
Is Biogen Pharmachem Industries' FCF Margin % too high?
Biogen Pharmachem Industries' current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.21 to a high of 404,066.67. Based on the distribution chart, Biogen Pharmachem Industries ranks #999999 out of 773 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, Biogen Pharmachem Industries has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biogen Pharmachem Industries' FCF Margin % compare to MS and GS?
According to the Capital Markets industry distribution chart, Biogen Pharmachem Industries ranks #999999 out of 773 companies for FCF Margin %. This places Biogen Pharmachem Industries in the lower half of its industry. The industry median FCF Margin % is 1.02. Historically, Biogen Pharmachem Industries' own FCF Margin % has ranged from 9.21 to 404,066.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Capital Markets company?
The median FCF Margin % among Capital Markets companies is 1.02, based on 773 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biogen Pharmachem Industries and its competitors. For the Capital Markets industry, the median FCF Margin % is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogen Pharmachem Industries's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogen Pharmachem Industries stock overvalued right now?
Biogen Pharmachem Industries (BOM:531752) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Biogen Pharmachem Industries' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Biogen Pharmachem Industries (BOM:531752), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biogen Pharmachem Industries Business Description

Address Jawahar Road, Shop No. 8, First Floor, Makers-1 Building, Rajkot, GJ, IND, 360001
Biogen Pharmachem Industries Ltd is engaged in the business of trading in shares and securities in the present and future markets.
30GF Score

Get the complete analysis for BOM:531752

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.31
Price